References and Notes
1a
Romanenko VD.
Kukhar VP.
Chem. Rev.
2006,
106:
3868
1b
Romanenko VD.
Kukhar VP.
Tetrahedron
2008,
64:
6153
2a
Blackburn GM.
Chem. Ind. (London)
1981,
5:
134
2b
Berkowitz DB.
Bose M.
J. Fluorine
Chem.
2001,
112:
13
3a
Frank AW.
J. Org. Chem.
1965,
30:
3663
3b
Fonong T.
Burton DJ.
Pietrzyk DJ.
Anal. Chem.
1983,
55:
1089
4a
Martin SF.
Wong YL.
Wagman AS.
J. Org. Chem.
1994,
59:
4821
4b
Halazy S.
Ehrhard A.
Danzin C.
J.
Am. Chem. Soc.
1991,
113:
315
4c
McLennan AG.
Taylor GE.
Prescott M.
Blackburn GM.
Biochemistry
1989,
28:
3868
4d
Blackburn GM.
Perree TD.
Rashid A.
Bisbal C.
Lebleu B.
Chem. Scr.
1986,
26:
21
4e
Caplan NA.
Pogson CI.
Hayes DJ.
Blackburn
GM.
Bioorg.
Med. Chem. Lett.
1998,
8:
515
4f
Wang G.
Boyle N.
Chen F.
Rajappan V.
Fagan P.
Brooks JL.
Hurd T.
Leeds JM.
Rajwanshi VK.
Jin Y.
Prhavc M.
Bruice TW.
Cook PD.
J.
Med. Chem.
2004,
47:
6902
4g
Liu DG.
Gao Y.
Voigt JH.
Lee K.
Nicklaus MC.
Wu L.
Zhang ZY.
Terrence R.
Burke J.
Bioorg.
Med. Chem. Lett.
2003,
13:
3005
4h
Yao ZJ.
Ye B.
Wu XW.
Wang S.
Wu L.
Zhang ZY.
Terrence R.
Burke J.
Bioorg. Med. Chem.
1998,
6:
1799
5a
Thenappan A.
Burton DJ.
J.
Org. Chem.
1990,
55:
2311
5b
Burton DJ.
Sprague LG.
Pietrzyk DJ.
Edelmuth SH.
J.
Org. Chem.
1984,
49:
3437
6a
Wang Q.
Huang Z.
Ramachandran C.
Dinaut AN.
Taylor SD.
Bioorg. Med. Chem. Lett.
1998,
8:
345
6b
Taylor SD.
Kotoris CC.
Dinaut AN.
Chen MJ.
Tetrahedron
1998,
54:
1691
6c
Iorga B.
Eymery F.
Savignac P.
Tetrahedron
1999,
55:
2671
6d
Xu Y.
Qian L.
Prestwich GD.
Org.
Lett.
2003,
5:
2267
7a
Caplan NA.
Pogson CI.
Hayes DJ.
Blackburn
GM.
J. Chem. Soc., Perkin Trans.
1
2000,
3:
421
7b
Pham V.
Zhang W.
Chen V.
Whitney T.
Yao J.
Froese D.
Friesen AD.
Diakur JM.
Haque W.
J. Med. Chem.
2003,
46:
3680
7c
Benayoud F.
deMendonca DJ.
Digits CA.
Moniz GA.
Sanders TC.
Hammond GB.
J.
Org. Chem.
1996,
61:
5159
8a
Piettre SR.
Tetrahedron Lett.
1996,
37:
2233
8b
Piettre SR.
Tetrahedron Lett.
1996,
37:
4707
9a
Blackburn GM.
Brown D.
Martin SJ.
Parratt MJ.
J. Chem. Soc., Perkin Trans. 1
1987,
1:
181
9b
Inukai K.
Ueda T.
Muramatsu H.
J.
Org. Chem.
1964,
29:
2224
9c
McKenna CE.
Khawli LA.
J.
Org. Chem.
1986,
51:
5467
10
Iorga B.
Eymery F.
Savignac P.
Tetrahedron
Lett.
1998,
39:
3693
11
General Procedure
for the Preparation of α-Chloro-benzylphosphonates from α-Hydroxyphosphonates
A
solution of 1k (1.00 g, 3.46 mmol, 1.0
equiv) and Ph3P (1.36 g, 5.19 mmol, 1.5 equiv) in dry
CCl4 (10 mL) is refluxed for 8 h under argon. Then, the
mixture is evaporated under reduced pressure, and the semisolid
residue is extracted with PE. The combined extracts are filtered,
and the solvent is removed under reduced pressure. The crude material
was purified by flash column chromatography on silica gel to yield 3k as yellow oil (0.81 g, 76%). ¹H
NMR (300 MHz, CDCl3): δ = 1.26
(t, J = 7.0
Hz, 3 H), 1.35 (t, J = 7.0
Hz, 3 H), 4.00-4.14 (m, 2 H), 4.15-4.28 (m, 2
H), 5.00 (d, ²
J
PH = 15.2
Hz, 1 H), 7.73 (d, J = 8.6
Hz, 2 H), 8.25 (d, J = 8.6
Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl3): δ = 16.2
(d, ³
J
PC = 5.6
Hz), 16.4 (d, ³
J
PC = 5.7
Hz), 52.5 (d, ¹
J
PC = 156.4
Hz), 64.1 (d, ²
J
PC = 7.0
Hz), 64.6 (d, ²
J
PC = 7.0 Hz),
123.6, 129.8, 141.4, 148.0 ppm.
12
General Procedure
for the Preparation of α,α-Chloro-fluorobenzylphosphonates
from α-Chlorophosphonates
To a solution of
the α-chlorophosphonates 3k (0.31
g, 0.94 mmol, 1.0 equiv) in dry THF (10 mL) at -78 ˚C
was added dropwise a solution of NaHMDS (1.69 mmol, 2.0 M in THF, 1.5
equiv) in dry THF (5 mL) under argon. The resulting dark green solution
was stirred for 1 h at -78 ˚C. A solution of NFSI
(0.41 g, 1.31 mmol, 1.3 equiv) in dry THF (5 mL) was added over
a period of 10 min. After addition, the solution was stirred for
1 h and then allowed to warm to -30 ˚C. The reaction
was quenched with 0.01 N HC1, and the resulting solution was extracted
with CH2Cl2. The combined organic layer was
dried over MgSO4, and the solvent was removed under reduced
pressure. The crude material was purified via flash column chromatography
on silica gel to yield 4k as yellow oil
(0.24 g, 77%). ¹H NMR (300 MHz, CDCl3): δ = 1.25
(t, J = 7.0
Hz, 3 H), 1.41 (t, J = 7.0
Hz, 3 H), 4.05-4.19 (m, 2 H), 4.32-4.41 (m, 2
H), 7.86 (d, J = 8.5 Hz,
2 H), 8.29 (d, J = 8.6
Hz, 2 H) ppm; ¹³C NMR (75 MHz, CDCl3): δ = 16.3
(d, ³
J
PC = 15.0
Hz), 65.3 (d, ²
J
PC = 7.2
Hz), 66.2 (d, ²
J
PC = 7.1
Hz), 105.6 (dd, ¹
J
PC = 193.4
Hz, ¹
J
FC = 259.1
Hz), 123.4, 127.5 (d, ³
J
PC = 8.4
Hz), 142.5 (d, ²
J
PC = 21.0
Hz), 148.7 ppm. ³¹P NMR (121.5 MHz,
CDCl3): δ = 5.13
(d, ²
J
PF = 88.1
Hz) ppm.
13a
Differding E.
Ruegg GM.
Tetrahedron
Lett.
1991,
32:
3815
13b
Differding E.
Bersier PM.
Tetrahedron
1992,
48:
1595
13c
Gilicinski AG.
Pez GP.
Syvret RG.
Lal GS.
J.
Fluorine Chem.
1992,
59:
157
13d
Christe KO.
J. Fluorine Chem.
1984,
25:
269
13e
Cartwright MM.
Woolf AA.
J.
Fluorine Chem.
1984,
25:
263
14 We thank one of the reviewers for
pointing out these possibilities.